News for Replimune Group, Inc. (7R8.F)

Published at

Feb 9, 2021 6:15 PM

by gurufocus.com

mixed

mixed

Steven Cohen Ups the Ante on Affimed

Steven Cohen Ups the Ante on Affimed, Stocks: AFMD,BMRN,NVAX,VRTX,INCY,REPL,MRSN, Steven Cohen, release date:Feb 09, 2021

NVV1.MU NVV1.F NVV1.BE NVAX.MX AFMD A28.SG A28.MU A28.F A28.BE 7R8.MU 7R8.F 7R8.BE 0M4.F 0M4.BE REPL NVAX MRSN INCY BMRN BM8.MU BM8.F BM8.BE

Read more →
Published at

Feb 9, 2021 6:15 PM

by gurufocus.com

mixed

mixed

Steven Cohen Ups the Ante on Affimed

Steven Cohen Ups the Ante on Affimed, Stocks: AFMD,BMRN,NVAX,VRTX,INCY,REPL,MRSN, Steven Cohen, release date:Feb 09, 2021

NVV1.MU NVV1.F NVV1.BE NVAX.MX AFMD A28.SG A28.MU A28.F A28.BE 7R8.MU 7R8.F 7R8.BE 0M4.F 0M4.BE REPL NVAX MRSN INCY BMRN BM8.MU BM8.F BM8.BE

Read more →
Published at

Feb 4, 2021 2:00 PM

by benzinga.com

neutral

neutral

Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update

RP1: Initial data in new indications expected in 2021 in anti-PD1 failed NSCLC, anti-PD1 failed CSCC and CSCC solid organ transplant recipient patients; ...

REPL 7R8.MU 7R8.F 7R8.BE

Read more →